Quality Solutions That Reduce Compliance Risks in Clinical Trials

Choose from specialized solutions that help you increase quality and efficiency.

Person on computer running quality assurance check

Why QA Teams Love TransPerfect

Our knowledge and experience in Quality Management is evidenced by our ability to create and curate strategic solutions to improve day-to-day operations / reducing administrative burdens. We have 30+ years of experience customizing these solutions. Here are some of your options:

QMS Powered by Trial Interactive

Our suite of eClinical solutions—part of TransPerfect’s Trial Interactive™ offering—improves visibility, reduces timelines, enhances quality, and mitigates risk. Explore our solutions for quality management, training management, audit management, vendor oversight, quality documents, and more.

Learn More

Training and Development

We offer training support across any platform, in 200+ languages, and any subject matter. Our team centralizes your global learning requirements and manages the administrative work, so you can roll out your content quickly and cost-effectively.

Learn More

Language/Translation Solutions

Ensure conceptual equivalence and cultural appropriateness in any language, minimizing time-to-market, mitigating risk, and ensuring compliance in global studies.

Learn More

Your Partner in Risk Mitigation

Ensuring quality from R&D through commercialization is complex due to ever-evolving regulations, international policy, and corporate change, among many other variables. QA teams need all the support they can get to embed quality in the organizational culture through efficiencies such as digital and automated work streams, real-time oversight, e-learning, and translated quality documentation for multilingual operations.

Improved Outcomes by the Numbers

85% of clinical trials experience delays. Mitigating compliance risks by streamlining QA operations is a key strategy for preventing costly delays caused by CAPAs and inspection findings.

1.2 M

Saved by CRAs using our CTMS for day-to-day operations

7.5 k

Studies managed in Trial Interactive

100 +

TMFs rescued mid-study

3 k

eTMF study migrations completed

50 %

Faster site activation

News and Thought Leadership

Industry insights from our experts. We have the experience and solutions you need to navigate life sciences complexity and bring breakthroughs from lab to launch.

Regulatory Considerations for Paper COA Translations | What You Need to Know

Blog

Collecting data for a global clinical trial on paper COAs or managing a mixed-mode study that combines both paper and electronic formats means satisfying multiple regulatory bodies before a single patient enrolls. None of these entities operate on the same timeline or answer to each other. While paper instruments might seem more flexible to deploy because they don’t require electronic implementation, there are still process considerations based on the instrument’s ...

Regulatory Considerations for Paper COA Translations | What You Need to Know

Webinar

XTalks | eCOA: Has It Lived Up to the Promise? A Realistic Assessment for Today's Trials

Despite two decades of technological advancement, the debate between paper and electronic clinical outcome assessments (eCOA) remains unresolved. This webinar revisits the assumptions that continue to shape data collection strategies and examines whether current practice reflects ...

Webinar

SSCPs Are Not Labeling: Compliant AI Processes for Reduced Cost & Turnaround

In this fireside chat, TransPerfect Medical Device's President Marc Miller sits down with Dr. Keith Morel, VP of Regulatory Compliance at Qserve, to unpack a critical question facing medical device manufacturers under MDR: can you reduce the translation review process for ...

Success Stories

Top 10 Pharma Company Overhauls Global COA Program,Cutting Costs by 33% and Errors to Near Zero

Inconsistent standards, stretched timelines, and limited visibility were straining a top 10 pharma company's COA program. Discover how TransPerfect Life Sciences' centralization strategy delivered 99.7% accuracy, 40% less PM oversight, and 33% cost savings across the ...

Blog

Four Years In: What the EU Clinical Trial Regulation Has (and Hasn't) Delivered

When the EU Clinical Trial Regulation (EU CTR No 536/2014) went live for new submissions on January 31, 2022, it promised to transform how clinical trials are authorized and conducted across Europe: a single submission, one decision, and harmonized oversight. Four years in,...

Webinar

How to Make Your Academy Succeed at Global Scale—Lessons Learned on What Works and What Doesn’t

Most life sciences and MedTech companies launch a corporate academy with strong strategic intent, whether that’s executive sponsorship, a named platform, a dedicated budget, or a curriculum mapped to business goals. After launch, however, these same organizations all too often ...

Webinar

IMP Labeling Workflows That Reduce Relabeling Risk and Start-Up Delays

Investigational medicinal product (IMP) labeling sits at the heart of clinical trial supply, impacting departments across pharmaceutical organizations, from clinical operations and regulatory affairs to quality assurance and beyond. When labeling activities are managed across ...